<?xml version="1.0" encoding="UTF-8"?>
<p id="p0405">Harmonyl, an alkaloid, appeared to be the only compound that could act on phase 1 and also on other two phases: the autoproteolytic activation and the genomic RNA replication. This action was revealed by an in silico prediction (
 <xref rid="bib97" ref-type="bibr">Zhang, Lin et al., 2020</xref>) and, therefore, further experiment could reveal the effective multi target action of harmonyl against viral replication.
</p>
